J Korean Oncol Nurs.  2011 Feb;11(1):33-40.

Randomized Controlled Trial for Preventing Stomatitis and Discomfort among Acute Leukemic Patients

• Song CE
• So HS
• Ju D
• Kim EJ

Abstract

PURPOSE
This study compared the effect of two oral care agents on preventing stomatitis and discomfort for acute leukemic patients.
METHODS
A total of forty patients was enrolled and randomly assigned to sodium bicarbonate or chlorhexidine group. WHO oral toxicity scale was used for measuring stomatitis and Beck's subjective oral discomfort scale for evaluating oral comfort. Data was collected from August 2009 to February 2010. The data was analyzed using Chi-square test, Fisher's exact test, and Mann-Whitney test.
RESULTS
Data analyzed was thirty five one. The incidence of stomatitis was 47.4%, 68.8% in sodium bicarbonate and chlohexidine group respectively. The onset of stomatitis was about the 10th and 9th day after chemotherapy initiation, and the duration was 8.0 and 8.67 day respectively. The severity of stomatitis was highest on the 21st day after chemotherapy initiation. There were no statistical differences in the status of stomatitis and the levels of oral comfort during treatment periods.
CONCLUSION
Nurses should routinely assess oral cavity and encourage patients to do oral care actively from second to third week after chemotherapy initiation. Also sodium bicarbonate agent can be recommended to for preventing stomatitis.

Keyword

Randomized Controlled Trial; Stomatitis

MeSH Terms

Chlorhexidine
Humans
Incidence
Mouth
Sodium Bicarbonate
Stomatitis
Chlorhexidine
Sodium Bicarbonate

Figure

• 

  Fig. 1 Status of oral comfort by treatment periods.

Reference

1. Park HJ, Shin HS. The effects of mouth care with sterile normal saline on chemotherapy-induced oral stomatitis. J Nurs Acad Soc. 1995. 25:5–16.

2. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004. 100:9 Suppl. 1995–2025.

3. Sonis ST. Pathobiology of mucositis. Semin Oncol Nurs. 2004. 20:11–15.

4. Peterson DE. New strategies for management of oral mucositis in cancer patients. J Support Oncol. 2006. 4(2):9–13.

5. Avritscher EBC, Cooksley CD, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Semin Oncol Nurs. 2004. 20:3–10.

6. Shelton BK. Evidence-based care for the neutropenic patient with leukemia. Semin Oncol Nurs. 2003. 19:133–141.

7. Worthington HV, Clarkson JE, Eden TO. Interventions for prevention oral mucositis for patients with cancer receiving treatment(review). accessed on 10 January 2010. Available at: http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD000978/frame.html.

8. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestical mucositis. Cancer. 2004. 100:9 Suppl. 2026–2046.

9. Stricker CT, Sullivan JS. Evidence-based oncology oral care clinical practice guidelines: development, implementation, and evaluation. Clin J Oncol Nurs. 2003. 7:222–227.

10. Harris DJ, Eilers J, Harriman A, Cashavelly BJ, Maxwell C. Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clin J Oncol Nurs. 2008. 12:141–152.

11. Eilers J, Epstein JB. Assessment and measurement of oral mucositis. Semin Oncol Nurs. 2004. 20:22–29.

12. McGuire DB. Barriers and strategies in implementation of oral care standards for cancer patients. Support Care Cancer. 2003. 11:435–441.

13. Kim YH, Jun MH, Choi JS. Prevention of chemotherapy induced oral mucositis in patients with acute leukemia by the two oral care protocols. J Korean Acad Adult Nurs. 1997. 9:98–111.

14. Quinn B, Stone R, Uhlenhopp M, McCann S, Blijlevens N. Ensuring accurate oral mucositis assessment in the European Group for blood and marrow transplantation prospective oral mucositis audit. Eur J Oncol Nurs. 2007. 11:Suppl 1. S10–S18.

15. Beck S. Impact of a systematic oral care protocol on stomatitis after chemotherapy. Cancer Nurs. 1979. 2:185–199.

16. Park YJ. The influence of saline and betadine solution for gargle in leukemic patients receiving chemotherapy [master's thesis]. 1997. Kwangju: Chonnam National Univ..

17. Barker GJ, Epstein JB, Williams KB, Gorsky M. Raber-Durlacher JE. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer. 2005. 13:32–41.

18. Ramirez-Amador V, Anaya-Saavedra G, Crespo-Solis E, Camacho EI, Gonzalez-Ramirez I, Ponce-de-Leon S. Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy. Support Care Cancer. 2010. 18:639–646.

19. Djuric M, Hillier-Kolarov V, Belic A, Jankovic L. Mucositis prevention by improved dental care in acute leukemia patients. Support Care Cancer. 2006. 14:137–146.

20. Byun YS, Kim AK. Experimental study for construction of mouth care in chemotherapy patients. J Nurs Acad Soc. 1996. 26:428–442.

21. Rutledge D. Oncology nurses look to the latest evidence to treat mucositis. ONS News. 2005. 20(2):1–6.